Mehmet Oz

Dr. Mehmet Oz, cardiothoracic surgeon turned CMS administrator focused on health policy and tech. He discusses AI and consumer tools reshaping primary care. They cover GLP-1 drugs, pricing and access. A deep dive into medical fraud, enforcement tactics and state accountability. Immigration, addiction and pragmatic approaches to care and enforcement are debated.

Dr. Mehmet Oz, the Administrator of CMS, sheds light on the alarming state of America's healthcare system. He reveals that despite spending the most on healthcare, life expectancy is declining. Childhood obesity rates are skyrocketing, with loneliness significantly driving health costs. The conversation stresses the need for a community-centered approach to tackle chronic diseases and improve overall health outcomes, especially for vulnerable populations like the elderly and children. A compelling discussion on reforming healthcare priorities!

Dr. Mehmet Oz, CMS administrator focused on drug prices and biotech innovation. Rep. Josh Gottheimer, New Jersey congressman tackling affordability, housing, and national security. They discuss the State of the Union reaction, drug pricing deals and preserving innovation, housing supply and permitting reform, and shifts in AI and safety policy. Conversations are concise, topical, and policy-forward.

Lisa Oz, author and integrative wellness commentator, and Dr. Mehmet Oz, cardiothoracic surgeon and CMS administrator, join for a wide-ranging conversation. They discuss Minnesota Medicaid fraud and systemic program integrity failures. They cover drug pricing, onshoring supply chains, stopping federal funding for child gender surgeries, health trends like intermittent fasting, and personal stories from public life.

Mehmet Oz, former administrator of the Centers for Medicare and Medicaid Services, dives into the growing concerns about Biden's health, revealing troubling testimonies from his aides. They discuss the implications of recent GDP growth, reflecting on consumer spending and investment trends. Additionally, Oz critiques the Democratic Party's response to healthcare challenges and the importance of technology in improving health outcomes. Tensions rise as they address insider trading controversies in Congress, highlighting integrity in political practices.

Dr. Mehmet Oz, physician and CMS administrator, outlines a massive Medicare and Medicaid fraud probe. He describes a 1,500% hospice surge in L.A., how organized crime weaponized home health, and the federal push for corrective action and law enforcement referrals. Short, sharp breakdowns of scale, harm to seniors, and state accountability.

Meet Josh Hammer, a constitutional lawyer explaining federal vs state power, and Dr. Mehmet Oz, a cardiothoracic surgeon and CMS administrator exposing alleged Medicare and Medicaid scams. They discuss massive hospice and home‑care fraud in Los Angeles. They also tackle clashes over federal officers, obstruction laws, the Supremacy Clause, and when protest crosses into illegality.

Dr. Mehmet Oz, CMS administrator and former TV physician, on Medicaid fraud and enforcement. Jonathan Savage, London-based foreign affairs correspondent, on the recent U.S.-Iran nuclear talks, regional military pressure, and the stakes for Saudi Arabia and Israel. Short, focused conversations on negotiations, sanctions relief, and systemic fraud in healthcare.

Finn Kennedy, a board member of MAHA Holdings, shares his inspiring journey with chronic illness while emphasizing the summit's mission to mobilize change. Dr. Mehmet Oz discusses vital reforms in Medicare and prevention-focused care. Vice President J.D. Vance explores innovative partnerships to revolutionize health policy. U.S. Secretary Robert F. Kennedy Jr. delivers a keynote on groundbreaking health reforms. Comedian Russell Brand wraps up with a thought-provoking commentary on health and culture, challenging us to rethink our approach.

Dr. Mehmet Oz, a former heart surgeon and health policy expert, dives into the White House's recent deals to lower GLP-1 obesity drug prices, highlighting the significant savings for Americans. He explains the disparities in drug pricing and the administration’s strategies to align U.S. costs with global standards. Oz also addresses the balance between pharma innovation and affordability. Additionally, Musk biographer Walter Isaacson discusses Tesla’s unprecedented $1 trillion pay package, evaluating Musk's history of exceeding expectations.